Adaptimmune Therapeutics
ADAP
#10851
Rank
NZ$26.13 M
Marketcap
NZ$0.09859
Share price
0.00%
Change (1 day)
11.29%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 20-F Annual Report 2015

20-F Annual Report 2015

Language: English

View Annual Report (20-F)
Thumbnail Adaptimmune Therapeutics 20-F Annual Report 2015

20-F Annual Report 2015

Language: English

View Annual Report (20-F)